Iraq War Veteran Suit Tepezza Claims Firm News search
Home > Ohio Blog > Stent Lawsuits and Endologix, Inc.’s Recent Bankruptcy Filings

Stent Lawsuits and Endologix, Inc.’s Recent Bankruptcy Filings

July 9, 2020 | 2 min read

On July 5, 2020, Endologix, Inc. filed for bankruptcy and will seek to reorganize. By law, this bankruptcy filing pauses legal proceedings against Endologix, including many stent lawsuits filed by Burg Simpson regarding Endologix’s recalled AFX AAA device. Despite this pause, those that have been injured by a defective Endologix stent should not wait to contact an attorney. It is critical that the bankruptcy court is aware of all those that have been harmed by the dangerous stents that were part of recent Endologix recalls. Contact Burg Simpson today to make sure your rights are protected.

As Burg Simpson previously reported, Endologix AAA stents have been subject to numerous recalls. In late 2016, the company issued a recall for AFX AAA stents due to their increased risk for Type III endoleaks. Type III endoleaks occur when there is either a separation between the stent components or when there is a tear or hole in the material. Type III endoleaks are serious medical conditions that can cause aneurysm expansion and rupture.

In 2018 and 2019, Endologix and the FDA provided the public with additional information on the grave risks associated with AFX devices. Specifically, the FDA reported that higher than expected risks of Type III endoleaks were occurring in patients treated with AFX endovascular graft devices based on prospective real-world data. Unsurprisingly, FDA has designated the Endologix AFX AAA recall as a Class I recall – the most serious type of recall, meaning that use of the recalled AFX device may cause serious injury or death. Burg Simpson has filed numerous defective stent lawsuits against Endologix on behalf of individuals who have been harmed by AFX devices.

In 2020 it became evident that AFX devices were not the only defective stents manufactured by Endologix. In June, FDA issued a Class I recall notice for the Ovation iX Abdominal Stent Graft System. According to the recall, components of the device may leak and enter the blood stream resulting in severe allergic type reactions, unstable blood pressure, tissue damage, organ failure, cardiac arrest, central nervous system problems, and death. This leakage may also cause the device to underinflate resulting in an endoleak and additional corrective procedures.

If you are a loved one suffered injuries as a result of an Endologix AFX or Ovation device, contact one of the experienced product liability attorneys at Burg Simpson today. Our award-winning lawyers would be happy to discuss your potential claim. Call 1-800-713-9340 or fill out our contact form for a FREE no-obligation consultation today.